FidoCure®
ActiveFidoCure® is the leader in Precision Medicine for Canine Oncology.
This company has previously operated under “The One Health Company”, “FidoCure”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!
Founders · 1
Related startups
Living therapies for pets first, and their people next
CCG.ai empowers clinicians to make personalised treatment strategies…
